NCOR2 and bladder transitional cell carcinoma: For example, in cervical squamous cell carcinoma and endocervical adenocarcinoma and ovarian serous cystadenocarcinoma, patients with elevated NCOR2 levels had shorter overall survival time, but in adrenocortical carcinoma and bladder urothelial carcinoma, there was no correlation between the NCOR2 level and overall survival (Figure S10A–D).